A major pharmaceutical company was considering creating an over-the-counter steroidal intranasal antihistamine for the pediatric market. Prior to launching a formal development program, they wanted to assess market readiness for such a concept.
Regulatory Challenges Market Acceptance Technical Feasibility
Maven conducted an Electronic Survey of five key populations, including Pharmacists, Pediatricians, Allergists, Ophthalmologists, and General Practitioners. The Survey sought perspectives on how such a drug would be received both by clinicians and the general public. The results revealed sharp differences of opinion between the different types of respondents, as well as an alternative concept with greater market readiness.
“The data from the wide variety of Healthcare Professionals in addition to the ease of receiving it has proven to be invaluable in helping us understand the challenges we could potentially face with bringing this product into an OTC setting.”
– Senior Director of Innovation Platforms